Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild‐to‐Moderate COVID ‐19 Cases in a Broadly Immune Population
Hadar Mudrik‐Zohar, Tim Cutfield, Susan Morpeth, Thomas Hills et autres
0 citationsThe Medical Journal of Australia
Susan Morpeth
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
4Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
COVID-19 Clinical Research StudiesAntibiotic Use and ResistanceSARS-CoV-2 and COVID-19 ResearchAntimicrobial Resistance in StaphylococcusVenous Thromboembolism Diagnosis and Management
Publications récentes
Duration of antibiotic therapy for bacteraemia in immune compromised hosts—a post-hoc subgroup analysis of the Bacteremia Antibiotic Length Actually Needed For Clinical Effectiveness (BALANCE) randomized clinical trial
Michelle Hamani, Ruxandra Pinto, Todd C. Lee, Derek MacFadden et autres
1 citationClinical Microbiology and Infection
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)
Madiha Hashmi, Rashan Haniffa, Deva Jayakumar, Abigail Beane et autres
1 citationCritical Care Medicine
Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: a randomized clinical trial
Charlotte Bradbury, Bryan J. McVerry, Patrick R. Lawler, Derek C. Angus et autres
2 citationsJournal of Thrombosis and Haemostasis
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022)
Nick Anagnostou, Sophia Archuleta, Eugene Athan, Lauren Barina et autres
0 citationsFigshare
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.